Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bubenik

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
International Journal of Oncology|May 17, 2011
IL-2 and gene-therapy of cancerJ Bubenik
International Journal of Oncology|May 11, 2011
Cytokine gene-modified vaccines for immunotherapy of cancer (review)J Bubenik
Pharmacology & Therapeutics|January 1, 1996
Cytokine gene-modified vaccines in the therapy of cancerJ Bubenik
Current Cancer Drug Targets|May 14, 2008
Genetically modified cellular vaccines for therapy of human papilloma virus type 16 (HPV 16)-associated tumoursJ Bubenik
The Veterinary Clinics of North America. Small Animal Practice|September 1, 2005
Infections of the skeletal systemLoretta J Bubenik
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 29, 2009
Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapyJ Bubenik, J Simova
Veterinary Surgery : VS|August 24, 2005
Bursting tension of medium and large canine arteries sealed with ultrasonic energy or suture ligationLoretta J Bubenik, Giselle Hosgood, Sunil C Vasanjee
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1975
Phenotypically mixed vesicular stomatitis virus particles produced in human tumor cell linesJ Zavada, J Bubenik, R Widmaier, et al.
Veterinary Surgery : VS|January 18, 2006
Evaluation of hemorrhage, sample size, and collateral damage for five hepatic biopsy methods in dogsSunil C Vasanjee, Loretta J Bubenik, Giselle Hosgood, et al.
International Journal of Oncology|May 14, 2011
Kinetics and function of peritoneal-exudate cells during local IL-2 gene-therapy of cancerJ Bubenik, J Zeuthen, M Indrova, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
International Journal of Oncology|May 17, 2011
IL-2 and gene-therapy of cancerJ Bubenik
International Journal of Oncology|May 11, 2011
Cytokine gene-modified vaccines for immunotherapy of cancer (review)J Bubenik
Pharmacology & Therapeutics|January 1, 1996
Cytokine gene-modified vaccines in the therapy of cancerJ Bubenik
Current Cancer Drug Targets|May 14, 2008
Genetically modified cellular vaccines for therapy of human papilloma virus type 16 (HPV 16)-associated tumoursJ Bubenik
The Veterinary Clinics of North America. Small Animal Practice|September 1, 2005
Infections of the skeletal systemLoretta J Bubenik
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 29, 2009
Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapyJ Bubenik, J Simova
Veterinary Surgery : VS|August 24, 2005
Bursting tension of medium and large canine arteries sealed with ultrasonic energy or suture ligationLoretta J Bubenik, Giselle Hosgood, Sunil C Vasanjee
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1975
Phenotypically mixed vesicular stomatitis virus particles produced in human tumor cell linesJ Zavada, J Bubenik, R Widmaier, et al.
Veterinary Surgery : VS|January 18, 2006
Evaluation of hemorrhage, sample size, and collateral damage for five hepatic biopsy methods in dogsSunil C Vasanjee, Loretta J Bubenik, Giselle Hosgood, et al.
International Journal of Oncology|May 14, 2011
Kinetics and function of peritoneal-exudate cells during local IL-2 gene-therapy of cancerJ Bubenik, J Zeuthen, M Indrova, et al.
Pageof 3